基于天然聚合物的药物输送系统的等离子体修饰技术.
Pankaj Bhatt1,2, Vipin Kumar2, Vetriselvan Subramaniyan3,4
1KIET School of Pharmacy, KIET Group of Institutions, Ghaziabad 201206, Uttar Pradesh, India.
Pharmaceutics
|August 26, 2023
概括
等离子处理通过改善表面特性来增强用于药物输送的天然聚合物. 这种可控制的技术为先进的医疗应用提供了更好的生物相容性,药物加载和释放.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 表面工程是什么?表面工程是什么?
背景情况:
- 天然聚合物对于药物输送具有多样性,但具有表面限制,如湿透性和粘附性差.
- 等离子处理通过修改天然聚合物表面来改善它们的药物递送能力提供了一个解决方案.
研究的目的:
- 审查基于天然聚合物的药物输送系统等离子体修饰的最新进展.
- 专注于可控制的等离子治疗技术及其应用.
主要方法:
- 血生成原理和过程控制的概述.
- 用于等离子体处理的天然聚合物表面的表征技术.
- 讨论在药物输送中的应用.
主要成果:
- 等离子处理增强了天然聚合物表面的特性,改善了可湿性,粘附性和药物加载/释放性.
- 改性聚合物显示出更好的生物相容性,受控释放,以及有针对性传递的潜力.
- 可控等离子体技术在表面功能化方面提供了多功能性.
结论:
- 血改性是优化药物输送系统中的天然聚合物的强大工具.
- 可控制的等离子处理提供了量身定制的表面特性,以提高性能.
- 这种方法在开发先进的药物输送车辆方面具有重大潜力.
相关概念视频
Drug Distribution: Plasma Protein Binding
5.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.7K
Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K


